Loading
companiesCompany
Verity Pharmaceuticals
Verity Pharmaceuticals is a Canadian specialty company that holds the US application for triptorelin (Trelstar) for advanced prostate cancer.
Overview
Verity Pharmaceuticals, based in Mississauga, Ontario, is a Canadian specialty company that holds the US application for triptorelin, sold as Trelstar, for advanced prostate cancer. It markets Trelstar, triptorelin pamoate, in North America and a portfolio of specialty medicines in Canada. OnCo links it to the triptorelin drug record. Whether older injectable hormone therapies keep their place as oral GnRH antagonists spread is the question that bears on its main oncology product. Triptorelin has its own page.
Headquarters
Mississauga, Ontario, CA
Scorecard
All companies#164of 1244 companies, score 36
- approved products +6
- targets +2
- modalities +2
- regions +1
- registry trials +25
1 approved, 0 in phase 3, 0 earlier, 1 targets, 152 registry studies. Formula on the scorecards page.
Type
Website
ApprovedGnRH agonist depot
Triptorelin · Trelstar
Triptorelin (Trelstar) is a one-, three- or six-monthly injection that switches off testosterone production for men with advanced prostate cancer.
Similar pages
- TrialEffect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer
Shares Triptorelin, Prostate cancer.
- CompanyTolmar
Shares GnRH receptor (GNRHR), Prostate cancer.
- TrialTriptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Shares Triptorelin, Prostate cancer.
- TreatmentBuserelin
Shares GnRH receptor (GNRHR), Triptorelin, Prostate cancer.
- TreatmentAbarelix
Shares GnRH receptor (GNRHR), Prostate cancer.
- TrialAssessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
Shares Triptorelin, Prostate cancer.
- TrialRadiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Shares Triptorelin, Prostate cancer.
- TreatmentHistrelin
Shares GnRH receptor (GNRHR), Prostate cancer.